BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 19507250)

  • 41. Dihydromyricetin sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating STAT1.
    He MH; Zhang Q; Shu G; Lin JC; Zhao L; Liang XX; Yin L; Shi F; Fu HL; Yuan ZX
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1702-1707. PubMed ID: 29225170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid.
    Jiang G; Albihn A; Tang T; Tian Z; Henriksson M
    Leuk Res; 2008 Feb; 32(2):297-307. PubMed ID: 17706770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1).
    Dimberg A; Bahram F; Karlberg I; Larsson LG; Nilsson K; Oberg F
    Blood; 2002 Mar; 99(6):2199-206. PubMed ID: 11877298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
    Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
    Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.
    Coradini D; Pellizzaro C; Scarlata I; Zorzet S; Garrovo C; Abolafio G; Speranza A; Fedeli M; Cantoni S; Sava G; Daidone MG; Perbellini A
    Leukemia; 2006 May; 20(5):785-92. PubMed ID: 16525489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression pattern of myeloid differentiation-related transcription factor mRNA in differentiation of NB4 and HL-60 cells induced by all-trans retinoic acid].
    Wu Y; Li XF; Yang JH; Liao XY; Huang HF; Chen YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):874-8. PubMed ID: 21867605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells.
    Zhang L; Yan Y; Zhu D; Yang W; Wang W; Hu Y; Yang B; He Q
    Invest New Drugs; 2012 Feb; 30(1):37-47. PubMed ID: 20686816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
    Barber N; Belov L; Christopherson RI
    Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line.
    Park HY; Park JY; Kim JW; Lee MJ; Jang MJ; Lee SY; Baek DW; Park YM; Lee SW; Yoon S; Bae YS; Kwak JY
    Int Immunopharmacol; 2004 Dec; 4(13):1587-601. PubMed ID: 15454112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17).
    Bullinger L; Schlenk RF; Götz M; Botzenhardt U; Hofmann S; Russ AC; Babiak A; Zhang L; Schneider V; Döhner K; Schmitt M; Döhner H; Greiner J
    Clin Cancer Res; 2013 May; 19(9):2562-71. PubMed ID: 23444226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MDI 301 suppresses myeloid leukemia cell growth in vitro and in vivo without the toxicity associated with all-trans retinoic acid therapy.
    Aslam MN; McClintock S; Khan SP; Perone P; Allen R; Ouillette PD; Dame MK; Cheng JX; Kunkel SL; Varani J
    Anticancer Drugs; 2015 Aug; 26(7):763-73. PubMed ID: 26010252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.
    Liu W; Lee HW; Liu Y; Wang R; Rodgers GP
    Blood; 2010 Dec; 116(23):4938-47. PubMed ID: 20724538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
    Zheng R; Wang X; Studzinski GP
    J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
    Meng H; Jin Y; Liu H; You L; Yang C; Yang X; Qian W
    J Hematol Oncol; 2013 Feb; 6():18. PubMed ID: 23415012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
    Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stress-induced NF-κB activation differentiates promyelocytic leukemia cells to macrophages in response to all-trans-retinoic acid.
    Imran M; Park JS; Lim IK
    Cell Signal; 2015 Mar; 27(3):694-706. PubMed ID: 25435432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen enhances the differentiation-inducing and growth-inhibitory effects of all-trans retinoic acid in acute promyelocytic leukemia cells.
    Adachi K; Honma Y; Miyake T; Kawakami K; Takahashi T; Suzumiya J
    Int J Oncol; 2016 Mar; 48(3):1095-102. PubMed ID: 26797574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells.
    Ozeki M; Shively JE
    J Leukoc Biol; 2008 Sep; 84(3):769-79. PubMed ID: 18552205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.